Home » Topics » BioWorld Science

BioWorld Science
RSS

First-in-human study of FS-118 in advanced solid tumors enrolling subjects

April 20, 2018

Otsuka launches Rexulti in Japan

April 20, 2018

Goofice tablet launched in Japan

April 20, 2018

CD163, VCAM-1 identified as markers of liver injury in autoimmune hepatitis

April 20, 2018

ApolloBio obtains license to Toca 511/Toca FC for greater China region

April 20, 2018

Phase II E4 Relief study of Donesta achieves primary objective

April 20, 2018

FDA grants fast track designation for balixafortide plus eribulin for metastatic breast cancer

April 20, 2018

Argos Therapeutics discontinues ADAPT study based on interim analysis results

April 20, 2018

FDA grants orphan drug designation for Oraxol for the treatment of angiosarcoma

April 20, 2018

Pfizer's novel ADC CD123-CPI has broad potential for treating acute myeloid leukemia

April 20, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.